A. Kant
Impact in
- Animal Science and Zoology top 0.5%
- Animal Virus Infections Studies
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
- Toxicology 12
- Pharmacovigilance and Adverse Drug Reactions 12
-
- COVID-19 Impact on Reproduction 9
- Co-authors
- G. KochOlof MoeskerP. H. K. JapD. J. van RoozelaarG. Peter VooijsD. HaagJ.J.G. PutsA. HUYSMANS
- Journals
- Drug Safety (7 papers)British Journal of Clinical Pharmacology (4 papers)Journal of Antimicrobial Chemotherapy (4 papers)Avian Pathology (3 papers)Journal of General Virology (3 papers)
- Partner nations
- NetherlandsCzechiaItaly
In The Last Decade
A. Kant
54 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 124
- Animal Science and Zoology 727
- Molecular Medicine 282
- Infectious Diseases 787
- Cell Biology 606
- Endocrinology 146
Countries citing papers authored by A. Kant
This map shows the geographic impact of A. Kant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Kant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Kant more than expected).
Fields of papers citing papers by A. Kant
This network shows the impact of papers produced by A. Kant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Kant. The network helps show where A. Kant may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A. Kant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 8 | |
| 6 | 2023 | 24 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 0 | |
| 10 | 2022 | 9 | |
| 11 | 2022 | 36 | |
| 12 | 2021 | 15 | |
| 13 | 2018 | 6 | |
| 14 | 2018 | 19 | |
| 15 | 2015 | 14 | |
| 16 | 2013 | 42 | |
| 17 | 1997 | 106 | |
| 18 | 1992 | 215 | |
| 19 | 1990 | 13 | |
| 20 | Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumors. Use in surgical pathology. | 1983 | 242 |
About A. Kant
A. Kant is a scholar working on Toxicology, Obstetrics and Gynecology, Infectious Diseases, Animal Science and Zoology and Molecular Medicine, having authored 56 papers that have together received 2.4k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (12 papers), COVID-19 Impact on Reproduction (9 papers), SARS-CoV-2 and COVID-19 Research (8 papers), Animal Virus Infections Studies (8 papers), Viral gastroenteritis research and epidemiology (7 papers), Reproductive System and Pregnancy (6 papers), Vaccine Coverage and Hesitancy (6 papers) and Skin and Cellular Biology Research (5 papers). The work is most often cited by research in Animal Science and Zoology (727 citations), Molecular Medicine (282 citations), Infectious Diseases (787 citations), Cell Biology (606 citations) and Endocrinology (146 citations). A. Kant has collaborated with scholars based in Netherlands, Czechia and Italy. Frequent co-authors include G. Koch, Olof Moesker, P. H. K. Jap, D. J. van Roozelaar, G. Peter Vooijs, D. Haag, J.J.G. Puts, A. HUYSMANS, C. J. Herman and Frans C. S. Ramaekers. Their work appears in journals such as Drug Safety, British Journal of Clinical Pharmacology, Journal of Antimicrobial Chemotherapy, Avian Pathology and Journal of General Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.